Vanguard Global Advisers’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
Vanguard Global Advisers's INMB Position: Q3 2026 in Review
Vanguard Global Advisers opened a new position in INmune Bio (INMB) in Q3 2026: 13,514 shares worth $26.4K. The stake represents ﹤0.01% of the portfolio and ranks #3276 among its holdings. This is a return to the name: Vanguard Global Advisers previously reported a position in INMB as recently as Q1 2026.
Vanguard Global Advisers first reported a position in INMB in Q1 2026 and has held it in 2 quarters since. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.
- Vanguard Global Advisers held 13,514 shares of INmune Bio worth $26.4K as of Q3 2026.
- INmune Bio was a new Vanguard Global Advisers position in Q3 2026.
- INmune Bio made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3276 holding.
- Vanguard Global Advisers first reported a position in INmune Bio in Q1 2026 and has held it in 2 quarters since.
- 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.